Jianqiao Liu

Jianqiao Liu

Auto-generated profile, based on publicly available information

Jianqiao Liu

Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital of Guangzhou Medical University , Guangzhou

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Molecular Therapy
Verified
Journal Article
Open access
YZYanting Zeng
Yanting Zeng
JLJianan Li
Jianan Li
GLGuanglei Li
Guanglei Li
SHShisheng Huang
Shisheng Huang
WYWenxia Yu
Wenxia Yu
XHXingxu Huang
Xingxu Huang
There are urgent demands for efficient treatment of heritable genetic diseases. The base editing technology has displayed its efficiency and precision in base substitution in human embryos, providing a potential early-stage treatment for genetic diseases. Taking advantage of this technology, we corrected a Marfan syndrome pathogenic mutation, FBN1T7498C. We first tested the feasibility in mutant cells, then successfully achieved genetic correction in heterozygous human embryos. The results showed that the BE3 mediated perfect correction at the efficiency of about 89%. Importantly, no off-target and indels were detected in any tested sites in samples by high-throughput deep sequencing combined with whole-genome sequencing analysis. Our study therefore suggests the efficiency and genetic safety of correcting a Marfan syndrome (MFS) pathogenic mutation in embryos by base editing.

14 December 2022 in Journal of Advanced Research
Verified
Journal Article
Open access
WZWei Zhang
Wei Zhang
SXSiyu Xia
Siyu Xia
WXWei Xiao
Wei Xiao
YSYali Song
Yali Song
LTLi Tang
Li Tang
JWJigang Wang
Jigang Wang
Advanced paternal age of reproduction is an increasing trend, especially in developed countries and areas. This trend results in elevated risks of adverse reproductive outcomes such as reduced fertility rates, increased pregnancy loss, and poor childhood health. Yet, a systematic profiling of aging-associated molecular and cellular alterations in testicular tissue is still missing. We aimed to dissect aging-associated molecular characteristics in testes of mice. Single-cell transcriptomic sequencing and analysis were conducted in testes of young (2 months old) and old mice (24 months old). Immunofluorescences and immunochemistry were used to characterize aging-associated phenotypes and verify single cell sequence results. Here, we constructed the first single-cell transcriptomic atlases of testes of young and old mice. In-depth dissection of aging-dependent transcriptional alterations in specific cell types revealed multiple dysregulated biological processes such as increased 'senescence-associated secretory phenotype' and 'inflammation', which were major aging-associated characteristics. Further analysis of aging-related differentially expressed genes uncovered a disrupted balance of undifferentiated and differentiated spermatogonia stem cells in spermatogonia, indicative of a potential role of spermatogonia stem cells in aging-associated subfertility. Importantly, for the first time, our results identified an increased subtype of aging-specific macrophages, which may contribute to a hostile proinflammatory microenvironment during testicular aging. Taken together, our findings depict the distinct single-cell transcriptional features of the aged mouse testes and provide enormous resources for a comprehensive understanding of the cell-type-specific molecular mechanisms underlying mouse testicular aging, which may shed light on developing novel potential diagnostic biomarkers and therapeutic targets for age-associated male subfertility.

19 August 2017 in Protein & Cell
Verified
Journal Article
Open access
PDF file
GLGuanglei Li
Guanglei Li
YLYajing Liu
Yajing Liu
YZYanting Zeng
Yanting Zeng
JLJianan Li
Jianan Li
LWLijie Wang
Lijie Wang
JLJianqiao Liu
Jianqiao Liu

31 May 2012 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
BYBolan Yu
Bolan Yu
HLHuanlan Lin
Huanlan Lin
LYLixia Yang
Lixia Yang
KCKang Chen
Kang Chen
HLHaihua Luo
Haihua Luo
ZHZhaofeng Huang
Zhaofeng Huang

21 November 2018 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
PXPei Xu
Pei Xu
BHBao-Yi Huang
Bao-Yi Huang
JZJia-Hui Zhan
Jia-Hui Zhan
MLMan-Ting Liu
Man-Ting Liu
YFYang Fu
Yang Fu
JLJian-Qiao Liu
Jian-Qiao Liu
Context Obese women usually need larger doses of FSH for ovarian stimulation, resulting in poor outcomes; however, the mechanism is still unclear. Objective To investigate the molecular regulation of FSH receptor (FSHR) expression associated with obesity. Design Case-control study to improve IVF outcomes. Patients Eighty-two obese and 457 overweight women undergoing IVF and 1,790 age-matched controls with normal weight from our reproductive medicine center. Intervention No special. Main Outcome Measures FSHR expression was decreased in parallel with BMI, while the oestradiol (E2) level on the hCG trigger day was significantly lower. Results FSHR expression in hGCs, both mRNA (P = 0.02) and protein (P = 0.001) levels, was decreased in overweight/obese women. Both insulin (P < 0.001) and glucose (P = 0.0017) levels were positively correlated with BMI in fasting blood and follicle fluids(FF) but not with FF leptin level. Treated KGN cells with insulin, E2 production was compromised, the level of p-Akt2 decreased while p-GSK3 increased, similar changes in hGCs from obese women. Stimulated hGCs from obese women with CP21, an inhibitor of GSK3β, resulting in upregulated β-catenin activation and increased FSHR expression. CP21 also increased the expression of IRS-1 and PI3K as well as the p-Akt2. Conclusions Obesity was associated with reduced FSHR expression and E2 production in IVF women, caused by dysfunctional insulin pathway. Decreased FSHR expression in hGCs from obese women and insulin-treated KGN could be rescued by inhibition of GSK3β, which might be a potential target for improving the impaired FSH response in obese women.

10 November 2022 in eLife
Verified
Journal Article
Open access
WLWenbo Liu
Wenbo Liu
XLXukun Lu
Xukun Lu
ZZZheng-Hui Zhao
Zheng-Hui Zhao
RSRuibao Su
Ruibao Su
QLQian-Nan Li Li
Qian-Nan Li Li
JLJianqiao Liu
Jianqiao Liu
Alternative splicing expands the transcriptome and proteome complexity and plays essential roles in tissue development and human diseases. However, how alternative splicing regulates spermatogenesis remains largely unknown. Here, using a germ cell-specific knockout mouse model, we demonstrated that the splicing factorSrsf10is essential for spermatogenesis and male fertility. In the absence of SRSF10, spermatogonial stem cells can be formed, but the expansion of Promyelocytic Leukemia Zinc Finger (PLZF)-positive undifferentiated progenitors was impaired, followed by the failure of spermatogonia differentiation (marked by KIT expression) and meiosis initiation. This was further evidenced by the decreased expression of progenitor cell markers in bulk RNA-seq, and much less progenitor and differentiating spermatogonia in single-cell RNA-seq data. Notably, SRSF10 directly binds thousands of genes in isolated THY+spermatogonia, andSrsf10depletion disturbed the alternative splicing of genes that are preferentially associated with germ cell development, cell cycle, and chromosome segregation, includingNasp,Bclaf1,Rif1,Dazl,Kit,Ret,andSycp1. These data suggest that SRSF10 is critical for the expansion of undifferentiated progenitors by regulating alternative splicing, expanding our understanding of the mechanism underlying spermatogenesis.